Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Want to see JP:4506 full AI Analyst Report?
Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of ¥610.31B. The enterprise value is ¥900.94B.
Market Cap¥610.31B
Enterprise Value¥900.94B
Share Statistics
Sumitomo Dainippon Pharma Co has 449,204,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding449,204,560
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 4.06%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.06%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee80.09M
Profits Per Employee4.75M
Employee Count4,980
Asset Turnover0.54
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is 5.1. Sumitomo Dainippon Pharma Co’s PEG ratio is 0.02.
PE Ratio5.1
PS Ratio1.82
PB Ratio2.82
Price to Fair Value1.71
Price to FCF12.29
Price to Operating Cash Flow―
PEG Ratio0.02
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of 398.83B and earned 23.63B in profits. Earnings per share was 59.49.
Revenue398.83B
Gross Profit225.38B
Operating Income22.42B
Pretax Income17.61B
Net Income23.63B
EBITDA51.73B
Earnings Per Share (EPS)59.49
Cash Flow
In the last 12 months, operating cash flow was 41.36B and capital expenditures -7.67B, giving a free cash flow of 33.69B billion.
Operating Cash Flow41.36B
Free Cash Flow33.69B
Free Cash Flow per Share75.00
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of ¥7, resulting in a dividend yield of ―
Dividend Per Share¥7
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.28
52-Week Price Change31.28%
50-Day Moving Average1.77K
200-Day Moving Average2.01K
Relative Strength Index (RSI)36.62
Average Volume (3m)5.45M
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is Aug 5, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 1.05, with Debt / Equity ratio of ―
Current Ratio1.05
Quick Ratio0.66
Debt to Market Cap1.05
Net Debt to EBITDA5.63
Interest Coverage Ratio2.62
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -6.02B in taxes.
Income Tax-6.02B
Effective Tax Rate-0.34
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is 11.23, with an EV/FCF ratio of 72.58.
EV to Sales1.46
EV to EBITDA11.23
EV to Free Cash Flow72.58
EV to Operating Cash Flow35.20
Balance Sheet
Sumitomo Dainippon Pharma Co has ¥20.45B in cash and marketable securities with ¥217.19B in debt, giving a net cash position of -¥288.79B billion.
Cash & Marketable Securities¥20.45B
Total Debt¥217.19B
Net Cash-¥288.79B
Net Cash Per Share-¥642.90
Tangible Book Value Per Share-¥504.51
Margins
Gross margin is ―, with operating margin of 5.62%, and net profit margin of 5.93%.
Gross Margin―
Operating Margin5.62%
Pretax Margin4.42%
Net Profit Margin5.93%
EBITDA Margin12.97%
EBIT Margin6.56%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is ¥1,500.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target¥1,500.00
Price Target Upside-19.12% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast13.66%
EPS Growth Forecast352.17%